| Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer JM Letourneau, EE Ebbel, PP Katz, A Katz, WZ Ai, AJ Chien, ME Melisko, ... Cancer 118 (6), 1710-1717, 2012 | 600 | 2012 |
| Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer JM Letourneau, EE Ebbel, PP Katz, KH Oktay, CE McCulloch, WZ Ai, ... Cancer 118 (7), 1933-1939, 2012 | 271 | 2012 |
| Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer JM Letourneau, JF Smith, EE Ebbel, A Craig, PP Katz, MI Cedars, ... Cancer 118 (18), 4579-4588, 2012 | 230 | 2012 |
| Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors EE Niemasik, J Letourneau, D Dohan, A Katz, M Melisko, H Rugo, ... Journal of Cancer Survivorship 6, 324-332, 2012 | 124 | 2012 |
| Response to ovarian stimulation is not impacted by a breast cancer diagnosis MM Quinn, H Cakmak, JM Letourneau, MI Cedars, MP Rosen Human Reproduction 32 (3), 568-574, 2017 | 84 | 2017 |
| Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer JM Letourneau, N Sinha, K Wald, E Harris, M Quinn, T Imbar, E Mok-Lin, ... Human reproduction 32 (10), 2123-2129, 2017 | 76 | 2017 |
| A changing perspective: improving access to fertility preservation JM Letourneau, ME Melisko, MI Cedars, MP Rosen Nature reviews Clinical oncology 8 (1), 56-60, 2011 | 60 | 2011 |
| Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy AJ Chien, J Chambers, F Mcauley, T Kaplan, J Letourneau, J Hwang, ... Breast cancer research and treatment 165, 151-159, 2017 | 57 | 2017 |
| Regret around fertility choices is decreased with pre-treatment counseling in gynecologic cancer patients JL Chan, J Letourneau, W Salem, AP Cil, SW Chan, L Chen, MP Rosen Journal of Cancer Survivorship 11, 58-63, 2017 | 53 | 2017 |
| Fertility preservation before breast cancer treatment appears unlikely to affect disease‐free survival at a median follow‐up of 43 months after fertility‐preservation consultation JM Letourneau, K Wald, N Sinha, F Juarez‐Hernandez, E Harris, ... Cancer 126 (3), 487-495, 2020 | 51 | 2020 |
| A View from the past into our collective future: the oncofertility consortium vision statement TK Woodruff, L Ataman-Millhouse, KS Acharya, T Almeida-Santos, ... Journal of assisted reproduction and genetics 38, 3-15, 2021 | 44 | 2021 |
| Contraception after cancer treatment: describing methods, counseling, and unintended pregnancy risk MM Quinn, JM Letourneau, MP Rosen Contraception 89 (5), 466-471, 2014 | 41 | 2014 |
| Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery JL Chan, J Letourneau, W Salem, AP Cil, SW Chan, L Chen, MP Rosen Gynecologic oncology 139 (1), 141-147, 2015 | 39 | 2015 |
| Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience L Aghajanova, V Sundaram, CN Kao, JM Letourneau, E Manvelyan, ... Journal of Assisted Reproduction and Genetics 38, 2955-2963, 2021 | 24 | 2021 |
| Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield JM Letourneau, H Cakmak, M Quinn, N Sinha, M I Cedars, MP Rosen Journal of Assisted Reproduction and Genetics 34, 1137-1144, 2017 | 23 | 2017 |
| Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield K Wald, H Cakmak, E Mok-Lin, M Cedars, M Rosen, J Letourneau Journal of assisted reproduction and genetics 36, 1161-1168, 2019 | 22 | 2019 |
| Accelerating ovarian age: cancer treatment in the premenopausal woman J Letourneau, SW Chan, MP Rosen Seminars in reproductive medicine 31 (06), 462-468, 2013 | 22 | 2013 |
| Fertility sparing surgery for localized ovarian cancers maintains an ability to conceive, but is associated with diminished reproductive potential J Letourneau, J Chan, W Salem, SW Chan, M Shah, E Ebbel, ... Journal of surgical oncology 112 (1), 26-30, 2015 | 21 | 2015 |
| The role of in-depth reproductive health counseling in addressing reproductive health concerns in female survivors of nongynecologic cancers MS Shah, JM Letourneau, EE Niemasik, M Bleil, CE McCulloch, ... Journal of psychosocial oncology 34 (4), 305-317, 2016 | 20 | 2016 |
| Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES … J Letourneau, F Juarez-Hernandez, K Wald, S Ribeiro, A Wang, ... Journal of Assisted Reproduction and Genetics 38, 2455-2463, 2021 | 15 | 2021 |
